Khayal Tamer I has filed 235 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 2407 shares of TransMedics Group, Inc. ($TMDX) on March 03, 2025.
Activity breakdown: 0 open-market purchases and 123 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2025 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2407 | $76.43 | 36,042.0000 | 35,216,837 | 6.26% | 0.01% |
| Feb. 24, 2025 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | A | Stock Option (Right to Buy) | 26499 | $0.00 | 26,499.0000 | 35,216,837 | 9999.99% | 0.08% |
| Feb. 24, 2025 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | A | Common Stock | 17606 | $0.00 | 38,449.0000 | 35,216,837 | 84.47% | 0.05% |
| Jan. 7, 2025 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1083 | $0.00 | 15,167.0000 | 35,216,837 | 6.66% | 0.00% |
| Jan. 7, 2025 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1083 | $13.28 | 21,926.0000 | 35,216,837 | 5.20% | 0.00% |
| Jan. 7, 2025 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1083 | $80.05 | 20,843.0000 | 35,216,837 | 4.94% | 0.00% |
| Dec. 2, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1084 | $0.00 | 16,250.0000 | 35,683,952 | 6.25% | 0.00% |
| Dec. 2, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1084 | $13.28 | 21,927.0000 | 35,683,952 | 5.20% | 0.00% |
| Dec. 2, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1084 | $86.40 | 20,843.0000 | 35,683,952 | 4.94% | 0.00% |
| Nov. 11, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1458 | $90.04 | 20,843.0000 | 35,683,952 | 6.54% | 0.00% |
| Nov. 11, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1458 | $0.00 | 5,834.0000 | 35,683,952 | 19.99% | 0.00% |
| Nov. 11, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1458 | $38.46 | 22,301.0000 | 35,683,952 | 7.00% | 0.00% |
| Nov. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1083 | $13.28 | 21,926.0000 | 35,683,952 | 5.20% | 0.00% |
| Nov. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1083 | $0.00 | 17,334.0000 | 35,683,952 | 5.88% | 0.00% |
| Nov. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1083 | $82.64 | 20,843.0000 | 35,683,952 | 4.94% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1458 | $0.00 | 7,292.0000 | 35,683,952 | 16.66% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1458 | $38.46 | 22,301.0000 | 35,683,952 | 7.00% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 417 | $66.10 | 22,718.0000 | 35,683,952 | 1.87% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1083 | $13.28 | 23,801.0000 | 35,683,952 | 4.77% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 823 | $146.15 | 22,978.0000 | 35,683,952 | 3.46% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 900 | $146.90 | 22,078.0000 | 35,683,952 | 3.92% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 80 | $147.98 | 21,998.0000 | 35,683,952 | 0.36% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 523 | $149.59 | 21,475.0000 | 35,683,952 | 2.38% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 318 | $150.38 | 21,157.0000 | 35,683,952 | 1.48% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 80 | $151.20 | 21,077.0000 | 35,683,952 | 0.38% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 80 | $152.28 | 20,997.0000 | 35,683,952 | 0.38% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 20 | $153.75 | 20,977.0000 | 35,683,952 | 0.10% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 134 | $154.86 | 20,843.0000 | 35,683,952 | 0.64% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 417 | $0.00 | 12,098.0000 | 35,683,952 | 3.33% | 0.00% |
| Oct. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1083 | $0.00 | 18,417.0000 | 35,683,952 | 5.55% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1459 | $38.46 | 22,302.0000 | 32,517,372 | 7.00% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 417 | $66.10 | 22,719.0000 | 32,517,372 | 1.87% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1084 | $13.28 | 23,803.0000 | 32,517,372 | 4.77% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 599 | $157.27 | 23,204.0000 | 32,517,372 | 2.52% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 921 | $158.09 | 22,283.0000 | 32,517,372 | 3.97% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 132 | $159.02 | 22,151.0000 | 32,517,372 | 0.59% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 396 | $160.67 | 21,755.0000 | 32,517,372 | 1.79% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 700 | $161.54 | 21,055.0000 | 32,517,372 | 3.22% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 80 | $163.09 | 20,975.0000 | 32,517,372 | 0.38% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 32 | $164.68 | 20,943.0000 | 32,517,372 | 0.15% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 100 | $165.87 | 20,843.0000 | 32,517,372 | 0.48% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1459 | $0.00 | 8,750.0000 | 32,517,372 | 14.29% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 417 | $0.00 | 12,515.0000 | 32,517,372 | 3.22% | 0.00% |
| Sept. 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1084 | $0.00 | 19,500.0000 | 32,517,372 | 5.27% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 124 | $157.00 | 22,036.0000 | 32,517,372 | 0.56% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1458 | $38.46 | 22,301.0000 | 32,517,372 | 7.00% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 417 | $66.10 | 22,718.0000 | 32,517,372 | 1.87% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1083 | $13.28 | 23,801.0000 | 32,517,372 | 4.77% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 114 | $151.80 | 23,687.0000 | 32,517,372 | 0.48% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 154 | $152.71 | 23,533.0000 | 32,517,372 | 0.65% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 483 | $153.81 | 23,050.0000 | 32,517,372 | 2.05% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 510 | $154.86 | 22,540.0000 | 32,517,372 | 2.21% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 380 | $155.69 | 22,160.0000 | 32,517,372 | 1.69% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 252 | $157.83 | 21,784.0000 | 32,517,372 | 1.14% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 240 | $158.88 | 21,544.0000 | 32,517,372 | 1.10% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 329 | $159.86 | 21,215.0000 | 32,517,372 | 1.53% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 126 | $161.09 | 21,089.0000 | 32,517,372 | 0.59% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 116 | $161.99 | 20,973.0000 | 32,517,372 | 0.55% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 32 | $163.65 | 20,941.0000 | 32,517,372 | 0.15% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 84 | $164.98 | 20,857.0000 | 32,517,372 | 0.40% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 14 | $166.00 | 20,843.0000 | 32,517,372 | 0.07% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1458 | $0.00 | 10,209.0000 | 32,517,372 | 12.50% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 417 | $0.00 | 12,932.0000 | 32,517,372 | 3.12% | 0.00% |
| Aug. 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1083 | $0.00 | 20,584.0000 | 32,517,372 | 5.00% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 110 | $149.57 | 23,691.0000 | 32,517,372 | 0.46% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1000 | $150.70 | 22,691.0000 | 32,517,372 | 4.22% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1458 | $38.46 | 22,301.0000 | 32,517,372 | 7.00% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1106 | $151.33 | 21,585.0000 | 32,517,372 | 4.87% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 582 | $152.53 | 21,003.0000 | 32,517,372 | 2.70% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 160 | $153.48 | 20,843.0000 | 32,517,372 | 0.76% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1458 | $0.00 | 11,667.0000 | 32,517,372 | 11.11% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 417 | $0.00 | 13,349.0000 | 32,517,372 | 3.03% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1083 | $0.00 | 21,667.0000 | 32,517,372 | 4.76% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 417 | $66.10 | 22,718.0000 | 32,517,372 | 1.87% | 0.00% |
| July 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1083 | $13.28 | 23,801.0000 | 32,517,372 | 4.77% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 417 | $0.00 | 13,766.0000 | 32,517,372 | 2.94% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1084 | $0.00 | 22,750.0000 | 32,517,372 | 4.55% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 219 | $130.79 | 23,479.0000 | 32,517,372 | 0.92% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1459 | $38.46 | 22,302.0000 | 32,517,372 | 7.00% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 417 | $66.10 | 22,719.0000 | 32,517,372 | 1.87% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1084 | $13.28 | 23,803.0000 | 32,517,372 | 4.77% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 105 | $129.92 | 23,698.0000 | 32,517,372 | 0.44% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 539 | $131.87 | 22,940.0000 | 32,517,372 | 2.30% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 921 | $132.71 | 22,019.0000 | 32,517,372 | 4.01% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 567 | $133.67 | 21,452.0000 | 32,517,372 | 2.58% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 152 | $134.66 | 21,300.0000 | 32,517,372 | 0.71% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 457 | $135.97 | 20,843.0000 | 32,517,372 | 2.15% | 0.00% |
| June 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1459 | $0.00 | 13,125.0000 | 32,517,372 | 10.00% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 11789 | $107.20 | 46,409.0000 | 32,517,372 | 20.26% | 0.04% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5313 | $110.00 | 26,226.0000 | 32,517,372 | 16.85% | 0.02% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 13078 | $109.68 | 31,539.0000 | 32,517,372 | 29.31% | 0.04% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1792 | $108.35 | 44,617.0000 | 32,517,372 | 3.86% | 0.01% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 14854 | $106.25 | 58,198.0000 | 32,517,372 | 20.33% | 0.05% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 11051 | $105.71 | 20,843.0000 | 32,517,372 | 34.65% | 0.03% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 100 | $123.66 | 20,843.0000 | 32,517,372 | 0.48% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 444 | $121.84 | 20,943.0000 | 32,517,372 | 2.08% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 422 | $121.21 | 21,387.0000 | 32,517,372 | 1.93% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1815 | $119.96 | 21,809.0000 | 32,517,372 | 7.68% | 0.01% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1417 | $119.00 | 23,624.0000 | 32,517,372 | 5.66% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 759 | $117.97 | 25,041.0000 | 32,517,372 | 2.94% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 326 | $116.80 | 25,800.0000 | 32,517,372 | 1.25% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 100 | $113.16 | 26,126.0000 | 32,517,372 | 0.38% | 0.00% |
| May 6, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5839 | $130.07 | 20,843.0000 | 32,517,372 | 21.88% | 0.02% |
| May 6, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5839 | $0.00 | 14,183.0000 | 32,517,372 | 29.16% | 0.02% |
| May 6, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 5839 | $66.10 | 26,682.0000 | 32,517,372 | 28.01% | 0.02% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1083 | $0.00 | 23,834.0000 | 32,517,372 | 4.35% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 45326 | $38.46 | 81,562.0000 | 32,517,372 | 125.09% | 0.14% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1458 | $38.46 | 83,020.0000 | 32,517,372 | 1.79% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1083 | $13.28 | 84,103.0000 | 32,517,372 | 1.30% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 23231 | $105.96 | 60,872.0000 | 32,517,372 | 27.62% | 0.07% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 12250 | $107.00 | 48,622.0000 | 32,517,372 | 20.12% | 0.04% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 3477 | $107.84 | 45,145.0000 | 32,517,372 | 7.15% | 0.01% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 3027 | $109.28 | 42,118.0000 | 32,517,372 | 6.71% | 0.01% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 15892 | $109.83 | 26,226.0000 | 32,517,372 | 37.73% | 0.05% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 100 | $113.16 | 26,126.0000 | 32,517,372 | 0.38% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 326 | $116.80 | 25,800.0000 | 32,517,372 | 1.25% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 738 | $117.96 | 25,062.0000 | 32,517,372 | 2.86% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1259 | $118.93 | 23,803.0000 | 32,517,372 | 5.02% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1799 | $119.85 | 22,004.0000 | 32,517,372 | 7.56% | 0.01% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 512 | $120.86 | 21,492.0000 | 32,517,372 | 2.33% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 532 | $121.74 | 20,960.0000 | 32,517,372 | 2.48% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 17 | $122.51 | 20,943.0000 | 32,517,372 | 0.08% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 100 | $123.66 | 20,843.0000 | 32,517,372 | 0.48% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 6888 | $110.06 | 28,731.0000 | 32,517,372 | 19.34% | 0.02% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 500 | $111.50 | 28,231.0000 | 32,517,372 | 1.74% | 0.00% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 7388 | $120.01 | 20,843.0000 | 32,517,372 | 26.17% | 0.02% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 45326 | $0.00 | 16,042.0000 | 32,517,372 | 73.86% | 0.14% |
| May 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1458 | $0.00 | 14,584.0000 | 32,517,372 | 9.09% | 0.00% |
| April 9, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 4980 | $91.11 | 51,012.0000 | 32,517,372 | 8.89% | 0.02% |
| April 9, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 10532 | $90.14 | 55,992.0000 | 32,517,372 | 15.83% | 0.03% |
| April 9, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 7171 | $38.46 | 66,524.0000 | 32,517,372 | 12.08% | 0.02% |
| April 9, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 8341 | $16.14 | 59,353.0000 | 32,517,372 | 16.35% | 0.03% |
| April 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 4388 | $90.00 | 51,012.0000 | 32,517,372 | 7.92% | 0.01% |
| April 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 4388 | $16.14 | 55,400.0000 | 32,517,372 | 8.60% | 0.01% |
| April 9, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 7171 | $0.00 | 61,368.0000 | 32,517,372 | 10.46% | 0.02% |
| April 9, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 8341 | $0.00 | 0.0000 | 32,517,372 | 100.00% | 0.03% |
| April 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 4388 | $0.00 | 8,341.0000 | 32,517,372 | 34.47% | 0.01% |
| April 4, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 4947 | $80.36 | 51,012.0000 | 32,517,372 | 8.84% | 0.02% |
| April 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5053 | $0.00 | 26,947.0000 | 32,517,372 | 15.79% | 0.02% |
| April 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5053 | $80.06 | 51,012.0000 | 32,517,372 | 9.01% | 0.02% |
| April 4, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 2917 | $16.14 | 55,959.0000 | 32,517,372 | 5.50% | 0.01% |
| April 4, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 2030 | $13.28 | 53,042.0000 | 32,517,372 | 3.98% | 0.01% |
| April 3, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 5053 | $13.28 | 56,065.0000 | 32,517,372 | 9.91% | 0.02% |
| April 4, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 2030 | $0.00 | 24,917.0000 | 32,517,372 | 7.53% | 0.01% |
| April 4, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 2917 | $0.00 | 12,729.0000 | 32,517,372 | 18.64% | 0.01% |
| March 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 100 | $16.14 | 52,429.0000 | 32,517,372 | 0.19% | 0.00% |
| March 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 100 | $90.04 | 52,329.0000 | 32,517,372 | 0.19% | 0.00% |
| March 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1317 | $87.63 | 51,012.0000 | 32,517,372 | 2.52% | 0.00% |
| March 8, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 100 | $0.00 | 15,646.0000 | 32,517,372 | 0.64% | 0.00% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1234 | $85.18 | 52,329.0000 | 32,517,372 | 2.30% | 0.00% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 3632 | $83.64 | 53,987.0000 | 32,517,372 | 6.30% | 0.01% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 10000 | $13.28 | 62,329.0000 | 32,517,372 | 19.11% | 0.03% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2868 | $81.49 | 59,461.0000 | 32,517,372 | 4.60% | 0.01% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1842 | $82.28 | 57,619.0000 | 32,517,372 | 3.10% | 0.01% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 32,000.0000 | 32,517,372 | 23.81% | 0.03% |
| March 1, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 424 | $84.26 | 53,563.0000 | 32,517,372 | 0.79% | 0.00% |
| Feb. 23, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | A | Common Stock | 12127 | $0.00 | 52,329.0000 | 32,517,372 | 30.17% | 0.04% |
| Feb. 23, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | A | Stock Option (Right to Buy) | 18690 | $0.00 | 18,690.0000 | 32,517,372 | 9999.99% | 0.06% |
| Feb. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1144 | $16.00 | 41,346.0000 | 32,517,372 | 2.85% | 0.00% |
| Feb. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1714 | $16.14 | 43,060.0000 | 32,517,372 | 4.15% | 0.01% |
| Feb. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2858 | $90.00 | 40,202.0000 | 32,517,372 | 6.64% | 0.01% |
| Feb. 20, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 250 | $16.14 | 40,452.0000 | 32,517,372 | 0.62% | 0.00% |
| Feb. 20, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 250 | $90.00 | 40,202.0000 | 32,517,372 | 0.62% | 0.00% |
| Feb. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1144 | $0.00 | 0.0000 | 32,517,372 | 100.00% | 0.00% |
| Feb. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1714 | $0.00 | 15,996.0000 | 32,517,372 | 9.68% | 0.01% |
| Feb. 20, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 250 | $0.00 | 15,746.0000 | 32,517,372 | 1.56% | 0.00% |
| Feb. 14, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 3050 | $90.03 | 40,202.0000 | 32,517,372 | 7.05% | 0.01% |
| Feb. 14, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 3050 | $16.00 | 43,252.0000 | 32,517,372 | 7.59% | 0.01% |
| Feb. 15, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 776 | $90.00 | 40,202.0000 | 32,517,372 | 1.89% | 0.00% |
| Feb. 15, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 776 | $0.00 | 1,144.0000 | 32,517,372 | 40.42% | 0.00% |
| Feb. 14, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 3050 | $0.00 | 1,920.0000 | 32,517,372 | 61.37% | 0.01% |
| Feb. 15, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 776 | $16.00 | 40,978.0000 | 32,517,372 | 1.93% | 0.00% |
| Feb. 7, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 736 | $0.00 | 4,970.0000 | 32,517,372 | 12.90% | 0.00% |
| Feb. 7, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 736 | $90.09 | 40,202.0000 | 32,517,372 | 1.80% | 0.00% |
| Feb. 7, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 736 | $16.00 | 40,938.0000 | 32,517,372 | 1.83% | 0.00% |
| Jan. 23, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 2330 | $0.00 | 5,706.0000 | 32,517,372 | 28.99% | 0.01% |
| Jan. 23, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2330 | $90.09 | 40,202.0000 | 32,517,372 | 5.48% | 0.01% |
| Jan. 23, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 2330 | $16.00 | 42,532.0000 | 32,517,372 | 5.80% | 0.01% |
| Jan. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 10000 | $13.28 | 50,202.0000 | 32,517,372 | 24.87% | 0.03% |
| Jan. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 9867 | $80.40 | 40,335.0000 | 32,517,372 | 19.65% | 0.03% |
| Jan. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 133 | $81.06 | 40,202.0000 | 32,517,372 | 0.33% | 0.00% |
| Jan. 16, 2024 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 42,000.0000 | 32,517,372 | 19.23% | 0.03% |
| July 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1461 | $0.00 | 68,539.0000 | 29,556,633 | 2.09% | 0.00% |
| July 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 3539 | $16.14 | 43,741.0000 | 29,556,633 | 8.80% | 0.01% |
| July 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1461 | $38.46 | 45,202.0000 | 29,556,633 | 3.34% | 0.00% |
| July 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5000 | $95.37 | 40,202.0000 | 29,556,633 | 11.06% | 0.02% |
| July 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 3539 | $0.00 | 17,710.0000 | 29,556,633 | 16.65% | 0.01% |
| July 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2225 | $90.02 | 40,202.0000 | 29,556,633 | 5.24% | 0.01% |
| July 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 2974 | $16.14 | 43,176.0000 | 29,556,633 | 7.40% | 0.01% |
| July 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2974 | $90.05 | 40,202.0000 | 29,556,633 | 6.89% | 0.01% |
| July 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 2974 | $0.00 | 21,249.0000 | 29,556,633 | 12.28% | 0.01% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 26,249.0000 | 29,556,633 | 27.59% | 0.03% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 10000 | $16.14 | 52,427.0000 | 29,556,633 | 23.57% | 0.03% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 2026 | $16.14 | 54,453.0000 | 29,556,633 | 3.86% | 0.01% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 8700 | $85.44 | 45,753.0000 | 29,556,633 | 15.98% | 0.03% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1300 | $86.09 | 44,453.0000 | 29,556,633 | 2.84% | 0.00% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2026 | $90.02 | 42,427.0000 | 29,556,633 | 4.56% | 0.01% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2775 | $90.04 | 42,427.0000 | 29,556,633 | 6.14% | 0.01% |
| April 21, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 2026 | $0.00 | 24,223.0000 | 29,556,633 | 7.72% | 0.01% |
| Feb. 28, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5000 | $80.06 | 45,202.0000 | 29,556,633 | 9.96% | 0.02% |
| Feb. 28, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 10000 | $16.14 | 55,202.0000 | 29,556,633 | 22.12% | 0.03% |
| Feb. 28, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 10000 | $80.15 | 45,202.0000 | 29,556,633 | 18.12% | 0.03% |
| Feb. 28, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 36,249.0000 | 29,556,633 | 21.62% | 0.03% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 777 | $73.55 | 71,055.0000 | 29,556,633 | 1.08% | 0.00% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 3751 | $0.00 | 46,249.0000 | 29,556,633 | 7.50% | 0.01% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 32179 | $0.00 | 8,036.0000 | 29,556,633 | 80.02% | 0.11% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 20000 | $75.15 | 50,202.0000 | 29,556,633 | 28.49% | 0.07% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 853 | $74.67 | 70,202.0000 | 29,556,633 | 1.20% | 0.00% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 6218 | $72.02 | 71,832.0000 | 29,556,633 | 7.97% | 0.02% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1763 | $71.46 | 78,050.0000 | 29,556,633 | 2.21% | 0.01% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 6319 | $70.18 | 79,813.0000 | 29,556,633 | 7.34% | 0.02% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 3751 | $16.14 | 86,132.0000 | 29,556,633 | 4.55% | 0.01% |
| Feb. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 32179 | $16.00 | 82,381.0000 | 29,556,633 | 64.10% | 0.11% |
| Feb. 20, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | A | Common Stock | 13075 | $0.00 | 50,202.0000 | 29,556,633 | 35.22% | 0.04% |
| Feb. 20, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | A | Stock Option (Right to Buy) | 20022 | $0.00 | 20,022.0000 | 29,556,633 | 9999.99% | 0.07% |
| Feb. 14, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 4070 | $0.00 | 40,215.0000 | 29,556,633 | 9.19% | 0.01% |
| Feb. 14, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 4070 | $16.00 | 41,197.0000 | 29,556,633 | 10.96% | 0.01% |
| Feb. 14, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 4070 | $70.15 | 37,127.0000 | 29,556,633 | 9.88% | 0.01% |
| Jan. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 3142 | $0.00 | 44,285.0000 | 29,556,633 | 6.62% | 0.01% |
| Jan. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 3142 | $16.00 | 40,269.0000 | 29,556,633 | 8.46% | 0.01% |
| Jan. 23, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 3142 | $65.07 | 37,127.0000 | 29,556,633 | 7.80% | 0.01% |
| Jan. 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 1300 | $16.00 | 38,427.0000 | 29,556,633 | 3.50% | 0.00% |
| Jan. 20, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5558 | $0.00 | 47,427.0000 | 29,556,633 | 10.49% | 0.02% |
| Jan. 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 1300 | $0.00 | 52,985.0000 | 29,556,633 | 2.39% | 0.00% |
| Jan. 20, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5558 | $65.21 | 37,127.0000 | 29,556,633 | 13.02% | 0.02% |
| Jan. 20, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 5558 | $16.00 | 42,685.0000 | 29,556,633 | 14.97% | 0.02% |
| Jan. 18, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 1300 | $65.11 | 37,127.0000 | 29,556,633 | 3.38% | 0.00% |
| Jan. 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 5900 | $16.00 | 43,027.0000 | 29,556,633 | 15.89% | 0.02% |
| Jan. 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5900 | $0.00 | 54,285.0000 | 29,556,633 | 9.80% | 0.02% |
| Jan. 13, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 5900 | $60.20 | 37,127.0000 | 29,556,633 | 13.71% | 0.02% |
| Jan. 3, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 2700 | $61.99 | 37,627.0000 | 29,556,633 | 6.70% | 0.01% |
| Jan. 3, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 900 | $60.93 | 40,327.0000 | 29,556,633 | 2.18% | 0.00% |
| Jan. 3, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Common Stock | 4100 | $16.00 | 41,227.0000 | 29,556,633 | 11.04% | 0.01% |
| Jan. 3, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | S | Common Stock | 500 | $62.79 | 37,127.0000 | 29,556,633 | 1.33% | 0.00% |
| Jan. 3, 2023 | TransMedics Group, Inc. | $TMDX | Khayal Tamer I | Chief Commercial Officer | M | Stock Option (Right to Buy) | 4100 | $0.00 | 60,185.0000 | 29,556,633 | 6.38% | 0.01% |